11.07.2015 Views

Guidelines on the Prevention and Control of Tuberculosis in Ireland

Guidelines on the Prevention and Control of Tuberculosis in Ireland

Guidelines on the Prevention and Control of Tuberculosis in Ireland

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<str<strong>on</strong>g>Guidel<strong>in</strong>es</str<strong>on</strong>g> <strong>on</strong> <strong>the</strong> Preventi<strong>on</strong> <strong>and</strong> C<strong>on</strong>trol <strong>of</strong> <strong>Tuberculosis</strong> <strong>in</strong> Irel<strong>and</strong> 2010HSE/HPSCHCWs-Tubercul<strong>in</strong> Sk<strong>in</strong> Test<strong>in</strong>gRecommendati<strong>on</strong>:HCWs from countries <strong>of</strong> high TB <strong>in</strong>cidence (≥ 40 cases <strong>of</strong> TB per 100,000 per year) with apositive TST (Mantoux test) def<strong>in</strong>ed as ≥ 10mm (table 2.1) should be referred to a respiratoryor <strong>in</strong>fectious disease cl<strong>in</strong>ician (with a chest X-ray) for a medical assessment to rule out TBdisease or LTBI. However, an occupati<strong>on</strong>al medic<strong>in</strong>e c<strong>on</strong>sultant may wish to treat <strong>the</strong>sepatients if appropriate protocols, audit <strong>of</strong> care <strong>and</strong> resources are <strong>in</strong> place.Irish HCWs or HCWs from low <strong>in</strong>cidence countries (< 40 cases <strong>of</strong> TB per 100,000 per year)with a positive TST (Mantoux test) def<strong>in</strong>ed as ≥ 15mm (table 2.1) should be referred to arespiratory or <strong>in</strong>fectious disease cl<strong>in</strong>ician (with a chest X-ray) for a medical assessment to ruleout TB disease or LTBI. However, an occupati<strong>on</strong>al medic<strong>in</strong>e c<strong>on</strong>sultant may wish to treat <strong>the</strong>sepatients if appropriate protocols, audit <strong>of</strong> care <strong>and</strong> resources are <strong>in</strong> place.Treatment for active TB should be c<strong>on</strong>sidered <strong>in</strong> HCWs with a positive TST (as outl<strong>in</strong>ed above) if <strong>the</strong> chestX-ray is abnormal, <strong>and</strong> treatment for LTBI if <strong>the</strong> chest X-ray is normal <strong>and</strong> signs <strong>and</strong> symptoms <strong>of</strong> diseaseare absent. IGRA test<strong>in</strong>g may be used as a c<strong>on</strong>firmatory test <strong>in</strong> those <strong>in</strong>dividuals with a positive TST.HCWs with active TB should not work while <strong>in</strong>fectious (chapter 6). They will be advised <strong>in</strong> this regard <strong>and</strong>when to return to work follow<strong>in</strong>g jo<strong>in</strong>t discussi<strong>on</strong> between <strong>the</strong> treat<strong>in</strong>g physician <strong>and</strong> <strong>the</strong> occupati<strong>on</strong>almedic<strong>in</strong>e c<strong>on</strong>sultant. The employer will need to c<strong>on</strong>sider each case <strong>in</strong>dividually tak<strong>in</strong>g account <strong>of</strong>employment <strong>and</strong> health <strong>and</strong> safety obligati<strong>on</strong>s. 329If HCWs with LTBI refuse treatment, <strong>the</strong> risk <strong>of</strong> develop<strong>in</strong>g TB disease should be expla<strong>in</strong>ed to <strong>the</strong>m<strong>in</strong>clud<strong>in</strong>g health <strong>and</strong> safety issues <strong>and</strong> <strong>the</strong> oral explanati<strong>on</strong> supplemented by written advice (see<strong>in</strong>formati<strong>on</strong> leaflet <strong>in</strong> appendix 6). In additi<strong>on</strong>, <strong>the</strong>y should be advised to report promptly to <strong>the</strong>occupati<strong>on</strong>al health department if <strong>the</strong>y become symptomatic. All HCWs should complete an annual healthquesti<strong>on</strong>naire <strong>and</strong> be given an annual rem<strong>in</strong>der <strong>of</strong> <strong>the</strong> signs <strong>and</strong> symptoms <strong>of</strong> TB disease <strong>and</strong> acti<strong>on</strong>srequired if <strong>the</strong>y become symptomatic (appendix 6).The follow<strong>in</strong>g groups should be <strong>in</strong>formed <strong>of</strong> <strong>the</strong> signs <strong>and</strong> symptoms <strong>of</strong> TB <strong>and</strong> advised to seek promptmedical attenti<strong>on</strong> if <strong>the</strong>y develop <strong>the</strong>se symptoms (see figure 9.1):• Employees from high <strong>in</strong>cidence countries (≥ 40 cases per 100,000 per year) with a TST result ≤10mm• All o<strong>the</strong>r employees with a TST result ≤ 15mm.-115-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!